5 Most Undervalued Stocks to Buy for Under $20
In this piece, we will take a look at the five most undervalued stocks to buy that are trading under $20.
Roivant Sciences Ltd. (ROIV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 1,600,000 | $16,864,000 | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 4,000,000 | Large Shareholder | 102,849,443 | 2022-11-10 | Filing | |
| $3.91 | 8,600 | Large Shareholder | 98,849,443 | 2022-04-25 | Filing | |
| $3.83 | 31,685 | Large Shareholder | 98,840,843 | 2022-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.92 | 96,950 | 532,207 | 2024-02-09 | Filing | ||
| $11.05 | 3,000,000 | Large Shareholder | 51,929,426 | 2024-01-02 | Filing | |
| $10.11 | 153,027 | 595,397 | 2023-10-05 | Filing | ||
| $10.25 | 606,221 | 595,397 | 2023-10-03 | Filing | ||
| $10.80 | 440,752 | 595,397 | 2023-10-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 73,031,667 | $820,145,620 | 7.29% | |
| 2. | 36,976,248 | $415,243,265 | 0.03% | |
| 3. | 21,927,044 | $246,240,711 | 0.02% | |
| 4. | 20,805,601 | $233,646,898 | 0% | |
| 5. | 13,727,418 | $154,158,904 | 0% |
News See All
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
Do You Think the Management of Roivant Sciences (ROIV) Can Create Value?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript
Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.27. Roivant Sciences Ltd.
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...
5 High Growth International Stocks to Buy
In this article, we discuss the 5 high growth international stocks to buy.
15 Best Fast Growth Stocks to Buy Now
In this article, we will take a look at the 15 best fast growth stocks to buy now.
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.